Showing results out of
Recent studies supported by EMBL Grenoble’s expertise in structural biology research and scientific services have identified Altiratinib as a potential drug to stop toxoplasmosis infection and opened up treatment options against malaria.
SCIENCE & TECHNOLOGY2022
sciencescience-technology
A group of scientists led by EMBL Hamburg’s Christian Löw provide insights into the molecular structure of proteins involved in the gliding movements through which the parasites causing malaria and toxoplasmosis invade human cells.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Parasite’s method of rewiring our immune response leads to novel tool for drug tests
SCIENCE & TECHNOLOGY2016
sciencescience-technology
No results found